Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Dong R, Jiang L, Yang T, Wang C, et al. Efficacy and Safety of SARS-CoV-2 Neutralizing Antibody JS016 in Hospitalized Chinese Patients with COVID-19: a Phase 2/3, Multicenter, Randomized, Open-Label, Controlled Trial. Antimicrob Agents Chemother 2022;66:e0204521.
PMID: 35191746


Privacy Policy